Skip to main content

Blume Capital Management, Inc.

Position in NVS — Novartis AG

CIK 1587192 BERKELEY, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$7,836
+$7,715 QoQ
Shares Held
50
+4900.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,550
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,836 50
2025-06-30 $121 1
2024-03-31 $14,509 150
2023-12-31 $75,727 750
2023-09-30 $137,511 1,350
2023-06-30 $100,910 1,000
2023-03-31 $92,000 1,000
2022-12-31 $18,144 200
2022-09-30 $15,202 200
2022-06-30 $16,906 200
2022-03-31 $17,550 200
2021-12-31 $2,375,510 27,158
2021-09-30 $851,575 10,413
2021-06-30 $945,520 10,363
2021-03-31 $232,334 2,718
2020-12-31 $18,886 200
2020-09-30 $17,392 200
2020-06-30 $17,468 200
2020-03-31 $16,490 200